European Companies Search Engine
EU funding (€260,348): DuoLipo-TNP: Dual-Responsive Liposome Platform for Selective Delivery of Triphosphate Nucleotide Prodrugs in Triple-Negative Breast Cancer Hor 27 Feb 2026 EU Research and Innovation programme "Horizon"
Overview
Text
This publication is not available.
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Fundação Gimm - Gulbenkian Institute For Molecular Medicine, Lisbon, Portugal.